MapLight Therapeutics (MPLT) 10% owner Novo Holdings A/S bought 952,941 shares for $16.2M at $17.00

Insider transactions reported

Novo Holdings A/S (10% owner at MapLight Therapeutics Inc., MPLT) reported that they bought 952,941 shares for $16.2M at $17.00, and acquired 2,733,681 shares on Oct 28, 2025. After these transactions the filing shows 3,686,622 shares held directly.

Reporting person

Novo Holdings A/S

Options and other derivatives

Holdings before and after

• Voting Common Stock: 0 to 3,686,622 direct
• Series C Preferred Stock: 26,191,207 to 0 direct
• Series D Preferred Stock: 19,734,671 to 0 direct

Footnotes from the filing

1. 1. The Series C Preferred Stock and Series D Preferred Stock automatically converted into voting common stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1-for-16.8 basis, and had no expiration date.
2. 2. Represents a purchase from the underwriters in the Issuer's initial public offering.

Transaction codes in this filing

Open-market purchase:

Code P marks a purchase in the open market or a private deal. The insider paid for these securities.

Conversion of a derivative:

Code C marks the conversion of a derivative, such as preferred stock or units, into another security.

FAQ